ExxonMobil Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | $3.78M | Sell |
33,937
-1,586
| -4% | -$177K | 0.11% | 209 |
|
|
2017
Q4 | $4.25M | Sell |
35,523
-5,234
| -13% | -$626K | 0.12% | 199 |
|
|
2017
Q3 | $5.72M | Sell |
40,757
-2,358
| -5% | -$331K | 0.14% | 172 |
|
|
2017
Q2 | $5.25M | Sell |
43,115
-6,764
| -14% | -$823K | 0.13% | 188 |
|
|
2017
Q1 | $6.05M | Sell |
49,879
-2,027
| -4% | -$246K | 0.13% | 181 |
|
|
2016
Q4 | $6.35M | Sell |
51,906
-5,353
| -9% | -$655K | 0.14% | 175 |
|
|
2016
Q3 | $7.02M | Sell |
57,259
-729
| -1% | -$89.3K | 0.15% | 168 |
|
|
2016
Q2 | $6.77M | Buy |
57,988
+3,135
| +6% | +$366K | 0.14% | 167 |
|
|
2016
Q1 | $7.64M | Buy |
54,853
+4,348
| +9% | +$605K | 0.17% | 140 |
|
|
2015
Q4 | $9.63M | Sell |
50,505
-1,411
| -3% | -$269K | 0.24% | 101 |
|
|
2015
Q3 | $8.12M | Buy |
51,916
+2,211
| +4% | +$346K | 0.21% | 118 |
|
|
2015
Q2 | $8.99M | Buy |
49,705
+1,092
| +2% | +$197K | 0.22% | 112 |
|
|
2015
Q1 | $8.43M | Buy |
48,613
+1,865
| +4% | +$323K | 0.19% | 128 |
|
|
2014
Q4 | $8.65M | Sell |
46,748
-1,725
| -4% | -$319K | 0.2% | 123 |
|
|
2014
Q3 | $8.04M | Sell |
48,473
-1,851
| -4% | -$307K | 0.19% | 132 |
|
|
2014
Q2 | $7.86M | Sell |
50,324
-1,486
| -3% | -$232K | 0.18% | 146 |
|
|
2014
Q1 | $7.88M | Buy |
51,810
+770
| +2% | +$117K | 0.18% | 140 |
|
|
2013
Q4 | $6.79M | Sell |
51,040
-951
| -2% | -$127K | 0.16% | 155 |
|
|
2013
Q3 | $6.04M | Sell |
51,991
-2,235
| -4% | -$260K | 0.15% | 165 |
|
|
2013
Q2 | $5M | Buy |
+54,226
| New | +$5M | 0.13% | 195 |
|